The Fund Raising Committee of the company at their meeting held on August 12, 2025, inter alia, considered and approved allotment of the same

Neogen Ionics has incorporated Wholly Owned Subsidiary named ‘Neogen Morita New Materials’

Neogen Ionics has incorporated Wholly Owned Subsidiary named ‘Neogen Morita New Materials’

The Board of Directors of Neogen Ionics, at its meeting held May 17, 2025, has approved the same

Board has approved execution of Share subscription agreement between the company and NCL Japan

The Board of Directors of the Company in its meeting scheduled to be held on August 5, 2023, inter alia, may also consider, evaluate and approve the same

Pursuant to the said transaction, BuLi Chem has become a wholly owned subsidiary of the company

Pursuant to the said transaction, BuLi Chem has become a wholly owned subsidiary of the company

The company will obtain the license from MUIS for proprietary and confidential manufacturing technology for making Neogen’s electrolyte solutions

This acquisition will boost Neogen’s portfolio by offering organolithium derivatives to existing pharma and agrochemical industries

This acquisition will boost Neogen’s portfolio by offering organolithium derivatives to existing pharma and agrochemical industries

This acquisition will boost Neogen’s portfolio by offering organolithium derivatives to existing pharma and agrochemical industries

The Board of Directors of the company at its meeting held on February 11, 2023 has considered and approved the same

The Board of Directors of the company at its meeting held on February 11, 2023 has considered and approved the same